In vivo, CD53 deletion in nonalcoholic steatohepatitis diet-fed mice blocked peripheral adipose accumulation and adipose inflammation, insulin tolerance, and liver lipid accumulation. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.